Department of Medical Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
Tissue Eng Part B Rev. 2023 Apr;29(2):167-187. doi: 10.1089/ten.TEB.2022.0033. Epub 2022 Oct 20.
Tissue Engineering (TE) is a branch of Regenerative Medicine (RM) that combines stem cells and biomaterial scaffolds to create living tissue constructs to restore patients' organs after injury or disease. Over the last decade, emerging technologies such as 3D bioprinting, biofabrication, supramolecular materials, induced pluripotent stem cells, and organoids have entered the field. While this rapidly evolving field is expected to have great therapeutic potential, its development from bench to bedside presents several ethical and societal challenges. To make sure TE will reach its ultimate goal of improving patient welfare, these challenges should be mapped out and evaluated. Therefore, we performed a systematic review of the ethical implications of the development and application of TE for regenerative purposes, as mentioned in the academic literature. A search query in PubMed, Embase, Scopus, and PhilPapers yielded 2451 unique articles. After systematic screening, 237 relevant ethical and biomedical articles published between 2008 and 2021 were included in our review. We identified a broad range of ethical implications that could be categorized under 10 themes. Seven themes trace the development from bench to bedside: (1) animal experimentation, (2) handling human tissue, (3) informed consent, (4) therapeutic potential, (5) risk and safety, (6) clinical translation, and (7) societal impact. Three themes represent ethical safeguards relevant to all developmental phases: (8) scientific integrity, (9) regulation, and (10) patient and public involvement. This review reveals that since 2008 a significant body of literature has emerged on how to design clinical trials for TE in a responsible manner. However, several topics remain in need of more attention. These include the acceptability of alternative translational pathways outside clinical trials, soft impacts on society and questions of ownership over engineered tissues. Overall, this overview of the ethical and societal implications of the field will help promote responsible development of new interventions in TE and RM. It can also serve as a valuable resource and educational tool for scientists, engineers, and clinicians in the field by providing an overview of the ethical considerations relevant to their work. Impact statement To our knowledge, this is the first time that the ethical implications of Tissue Engineering (TE) have been reviewed systematically. By gathering existing scholarly work and identifying knowledge gaps, this review facilitates further research into the ethical and societal implications of TE and Regenerative Medicine (RM) and other emerging biomedical technologies. Moreover, it will serve as a valuable resource and educational tool for scientists, engineers, and clinicians in the field by providing an overview of the ethical considerations relevant to their work. As such, our review may promote successful and responsible development of new strategies in TE and RM.
组织工程(TE)是再生医学(RM)的一个分支,它将干细胞和生物材料支架结合起来,构建活组织构建体,以恢复患者受伤或患病后的器官。在过去的十年中,3D 生物打印、生物制造、超分子材料、诱导多能干细胞和类器官等新兴技术已经进入该领域。虽然这个快速发展的领域有望具有巨大的治疗潜力,但它从实验室到临床的发展带来了一些伦理和社会挑战。为了确保 TE 将实现改善患者福利的最终目标,应该对这些挑战进行规划和评估。因此,我们对 TE 在再生目的方面的发展和应用的伦理含义进行了系统评价,这在学术文献中有所提及。在 PubMed、Embase、Scopus 和 PhilPapers 中进行搜索查询,共获得 2451 篇独特的文章。经过系统筛选,我们纳入了 2008 年至 2021 年间发表的 237 篇相关的伦理和生物医学文章。我们确定了广泛的伦理含义,可以分为 10 个主题。七个主题可以追溯到从实验室到临床的发展过程:(1)动物实验,(2)处理人体组织,(3)知情同意,(4)治疗潜力,(5)风险和安全,(6)临床转化,(7)社会影响。三个主题代表与所有发展阶段相关的伦理保障:(8)科学诚信,(9)监管,(10)患者和公众参与。本综述表明,自 2008 年以来,大量文献已经出现,探讨如何以负责任的方式设计 TE 的临床试验。然而,一些主题仍需要更多关注。这些主题包括临床试验以外替代转化途径的可接受性、对社会的软影响以及对工程组织的所有权问题。总的来说,本综述对该领域的伦理和社会影响进行了概述,将有助于促进 TE 和 RM 中新干预措施的负责任发展。它还可以作为该领域科学家、工程师和临床医生的宝贵资源和教育工具,为他们提供与工作相关的伦理考虑的概述。